Lipodystrophy Clinical Trials

81 clinical trials for Lipodystrophy across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD) — RECRUITING
• Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy — RECRUITING
• The LD Lync Study - Natural History Study of Lipodystrophy Syndromes — RECRUITING
• Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE" — RECRUITING · NA
• Low Energy Diet and Familial Partial Lipodystrophy — RECRUITING · NA
• Effects of Meal Macronutrients on Postprandial Lipids — NOT_YET_RECRUITING · PHASE2
• Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose) — COMPLETED · NA
• Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy — ACTIVE_NOT_RECRUITING · PHASE2
• Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy — ACTIVE_NOT_RECRUITING · PHASE3
• Identification of a New Gene Involved in Hereditary Lipodystrophy — COMPLETED · NA
• Study of the Subdermal Implant "Ultracol" — COMPLETED · NA
• Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity — COMPLETED
• Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling — OTHER
• The Cleveland Cardiometabolic Cohort — COMPLETED
• Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance — COMPLETED
• Carotid Doppler Peak Velocity Variation in Liposuction Fluid Management — COMPLETED · NA
• Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling Treatment — COMPLETED
• Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula — COMPLETED · NA
• Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects — OTHER · NA
• Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy — COMPLETED · NA
• Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects — OTHER · NA
• Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects — OTHER · NA
• Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue Defects — COMPLETED · NA
• Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects — COMPLETED · NA
• TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy — COMPLETED · PHASE3
• Growth Hormone Dynamics and Cardiac Steatosis in HIV — COMPLETED
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids — COMPLETED · PHASE3
• The PREFORM Study: Rotational Fractional Resection for Submental Contouring — COMPLETED · NA
• Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. — OTHER · PHASE3
• CONFORM: Rotational Fractional Resection for Submental Contouring — COMPLETED · NA
• Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference — TERMINATED · NA
• Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension — COMPLETED · PHASE2
• Insulin Regulated Amino Peptidase in Patients With Familial Lipodystrophy of DUNNIGAN — COMPLETED
• Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients. — COMPLETED
• Short-term Effects of Leptin in People With Lipodystrophy — COMPLETED · PHASE2
• Therapeutic Approaches to HAART-Induced Lipodystrophy — COMPLETED · PHASE2
• Lipodystrophy Connect Patient Registry — COMPLETED
• Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat — COMPLETED · NA
• Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients — COMPLETED · PHASE3
• Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances — COMPLETED
• Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS — COMPLETED · NA
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy — COMPLETED · PHASE2
• Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults — COMPLETED · PHASE2
• Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) — COMPLETED
• Egrifta Replacement and Sleep Disordered Breathing — WITHDRAWN
• Leptin to Treat Lipodystrophy — COMPLETED · PHASE2
• Metabolic Abnormalities in HIV-infected Persons — COMPLETED · PHASE4
• The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS — COMPLETED · NA
• Lactate Metabolism Study in HIV Infected Persons — COMPLETED · PHASE4
• Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers — COMPLETED · PHASE1

Refine this search